Manufacturing & Engineering
For organisations in the manufacturing and engineering arena, even seemingly simple products and projects have vastly complex operations behind them.
Safeguarding IP in pioneering manufacturing processes or software engineering systems is vital to secure and build market share. Supply chains must be well-managed both upstream and downstream to drive efficiency and reduce risk. Outsourcing arrangements and sub-contractor relationships must enhance rather than undermine operational delivery. And mobilising and retaining staff with the right skills and talent holds the keys to unlocking growth and innovation.
We are renowned as the go-to law firm for creators, makers and innovators – the kinds of dynamic businesses like yours which need access to insightful and forward-looking legal advice if they are to make the most of the opportunities in an increasingly competitive marketplace. Our lawyers understand the need to make the complex simple, supporting both leading names and niche businesses from food & beverage to consumer goods, healthcare to construction, and automotive to software for all their legal requirements from the running of their day-to-day business to major strategic transactions.
European Medicines Agency produces Q&A document on impact of Brexit for MA holders24 July 2017
As the UK prepares to leave the EU, the holders of marketing authorisations for human or veterinary centrally approved need to ensure that that they take appropriate steps to ensure that they comply with the establishment requirements in the EU/EEA.
HR Academy Advanced17 July 2017
Following on from our popular HR Academy, the HR Academy Advanced is a one day course suitable for more experienced HR professionals or those looking for a deeper insight into some of the more complicated areas of employment law.
Squeezed out of validity and into the jurisdiction13 July 2017
UCB licensed Chugai rights to its tocilizumab patents. The licence contained an exclusive jurisdiction clause in favour of the English courts. Only one US patent remained in force. Chugai wanted a declaration that its tocilizumab products (sold only in the US) fell outside of the scope of the last patent and accordingly no royalty payments were due under the licence.
Sandoz & Hexal v Searle & Janssen Sciences Ireland: What is the formula for patent extensions?13 July 2017
The UK High Court has held that a pharmaceutical product claimed only within a Markush formula and not expressly referred to in the patent was protected by the patent for the purposes of obtaining a Supplementary Protection Certificate (SPC).
UPC – UK moves forward whilst Germany stalls13 July 2017
The Unified Patent Court (UPC) is intended to provide a regional forum resolve patent disputes. UPC decisions will have effect in all 25 states participating in the UPC, providing a single forum to resolve disputes.
Brands and IP newsnotes - issue 527 June 2017
Welcome to the 5th edition of our Brands & IP newsnotes put together to bring you the latest, and most interesting legal developments affecting intellectual property law. In this issue we cover; the potential pitfalls of social media, design by artificial intelligence, interesting trade mark applications and cases, an update on the UPC, and the importance of protecting trade secrets.
Beware of handing matters over to the court’s discretion16 June 2017
How often in negotiations do parties “duck” issues deemed “too difficult” and try to cope with them by adopting “reasonable” (or other) “endeavours” obligations?
Warranty and Indemnity Insurance – the what, why and how of it?13 June 2017
Whilst the use of W&I Insurance in M&A transactions has been available for some time, its use has increased dramatically in the past few years, particularly in the technology, real estate and manufacturing sectors.